2026-01-09
眼科基因治疗技术研究商
医药研发/制造
化学&生物药
RD Fund;
RD Fund;
Syncona;
Syncona;
Forbion Capital Partners;
Oxford Science Enterprises;
Advent Life Sciences;
2026-01-09
创新药物研发商
医药研发/制造
化学&生物药
赛诺菲;
赛诺菲;
Janus Henderson Investors;
Janus Henderson Investors;
Atlas Venture;
BVF Partners;
Lightspeed Venture Partners;
RA Capital;
Frazier Management;
Viking Global Investors;
RV Invest;
Velosity Capital;
Biovision Ventures;
Checkpoint Capital;
Deep Track Capital;
EcoR1 Capital;
Logos Capital;
Balyasny Asset;
Woodline Partners;
2026-01-08
抗体靶向疗法开发商
医药研发/制造
化学&生物药
GV;
GV;
Johnson & Johnson Development Corporation;
Johnson & Johnson Development Corporation;
诺华;
维梧资本;
Polaris Partners;
Digitalis Ventures;
Taiho Ventures;
Codon Capital;
Mission BioCapital;
Avego Bioscience Capital;
Samsara BioCapital;
2026-01-08
抗癌新药研发商
医药研发/制造
化学&生物药
Janus Henderson Investors;
Janus Henderson Investors;
富达国际;
富达国际;
RA Capital;
Sixty Degree Capital;
Catalio Capital Management;
Samsara BioCapital;
HBM Healthcare;
Rock Springs Capital;
Foresite Capital;
Farallon Capital Management;
Invus;
General Catalyst;
Marshall Wace;
T. Rowe Price;
GV;
Milky Way Investments;
ARCH Venture Partners;
Nextech Invest;
鱼鹰资管;
VenBio Partners;
Soleus Capital;
Frazier Management;
2026-01-08
胸腺再生疗法开发商
医药研发/制造
化学&生物药
勃林格殷格翰风险基金;
勃林格殷格翰风险基金;
LifeSpan Vision;
LifeSpan Vision;
CARMA Fund;
Eos Bioinnovation;
High-TechGründerfonds;
2026-01-08
肥胖和代谢疾病疗法开发商
医药研发/制造
化学&生物药
Omega Funds;
Omega Funds;
Andera Partners;
Andera Partners;
New Rhein;
Avego Bioscience Capital;
Kurma Partners;
2026-01-07
新型治疗药物研发商
医药研发/制造
AI+制药
Surveyor Capital;
Surveyor Capital;
Breyer Capital;
Breyer Capital;
GordonMD Global Investments;
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
